Carnomed d.o.o., in cooperation with the Medical Faculty, University of Novi Sad, would like to inform you about research results we have obtained. We have used the animal model of multiple sclerosis in mice.
This research has shown significant and very important results and we would like to share them with you.
Significantly reduces symptoms in mice suffering from multiple sclerosis.
The inflammatory infiltrate is reduced and smaller areas of demyelination are observed at doses of 6 capsules per day.
Karnozin Extra, even at high doses, did not show any harmful effect on the heart, lungs, liver, kidneys, brain, pancreas, spleen, testis and digestive tract tissues. That qualify our product as highly safe for usage
Histological and morphological analyses have not detected any structural and functional changes in the cells of the above mention tissues. This finding qualifies our product Karnozin Extra as a highly safe product for usage, since no adverse effects have been observed.
For more information, please contact us: email@example.com